Applied DNA Sciences Inc. (NASDAQ: APDN) started the day on April 07, 2021, with a price increase of 13.20% at $8.23. During the day, the stock rose to $9.96 and sunk to $7.90 before settling in for the price of $7.27 at the close. Taking a more long-term approach, APDN posted a 52-week range of $3.61-$16.39.
The Industrials Sector giants’ yearly sales growth during the last 5-year period was -26.50%. Meanwhile, its Annual Earning per share during the time was 33.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 65.70%. This publicly-traded company’s shares outstanding now amounts to $7.47 million, simultaneously with a float of $6.12 million. The organization now has a market capitalization sitting at $58.19 million. At the time of writing, stock’s 50-day Moving Average stood at $9.35, while the 200-day Moving Average is $8.30.
Let’s gauge the efficiency of the firm, which has a total of 59 employees. It has generated 31,664 per worker during the last fiscal year. Meanwhile, its income per employee was -213,561. The stock had 3.73 Receivables turnover and 0.26 Total Asset turnover. For the Profitability, stocks gross margin was +47.88, operating margin was -648.98 and Pretax Margin of -674.55.
Applied DNA Sciences Inc. (APDN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Security & Protection Services Industry. Applied DNA Sciences Inc.’s current insider ownership accounts for 10.47%, in contrast to 10.00% institutional ownership. According to the most recent insider trade that took place on Mar 10, this organization’s Director sold 13,049 shares at the rate of 8.43, making the entire transaction reach 110,042 in total value, affecting insider ownership by 250. Preceding that transaction, on Jun 26, Company’s ex 5% owner bought 110,000 for 5.25, making the whole transaction’s value amount to 577,500. This particular insider is now the holder of 245,000 in total.
Applied DNA Sciences Inc. (APDN) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported -$0.88 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.54) by -$0.34. This company achieved a net margin of -674.46 while generating a return on equity of -534.26. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
Applied DNA Sciences Inc.’s EPS increase for this current 12-month fiscal period is 65.70% and is forecasted to reach -0.03 in the upcoming year.
Applied DNA Sciences Inc. (NASDAQ: APDN) Trading Performance Indicators
Let’s observe the current performance indicators for Applied DNA Sciences Inc. (APDN). It’s Quick Ratio in the last reported quarter now stands at 2.10. The Stock has managed to achieve an average true range (ATR) of 0.76. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 20.06.
In the same vein, APDN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.19, a figure that is expected to reach -0.24 in the next quarter, and analysts are predicting that it will be -0.03 at the market close of one year from today.
Technical Analysis of Applied DNA Sciences Inc. (APDN)
If we take a close look at the recent performances of Applied DNA Sciences Inc. (NASDAQ: APDN), its last 5-days Average volume was 2.05 million that shows progress from its year to date volume of 1.49 million. During the previous 9 days, stock’s Stochastic %D was recorded 32.21% While, its Average True Range was 0.82.
Raw Stochastic average of Applied DNA Sciences Inc. (APDN) in the period of the previous 100 days is set at 37.74%, which indicates a major fall in contrast to 43.46% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 87.16% that was lower than 161.45% volatility it exhibited in the past 100-days period.